Thyroid eye disease in the context of autoimmune polyglandular syndromes: comparative clinical insights from a retrospective study. [PDF]
Croce L +8 more
europepmc +1 more source
Targeting IL-6 Receptor Signaling with Satralizumab in Thyroid Eye Disease: Design of the Phase 3 SatraGO-1 and SatraGO-2 Trials. [PDF]
Ezra D +7 more
europepmc +1 more source
Efficacy and safety of various Intravenous Methylprednisolone regimens in Moderate to Severe Thyroid Eye Disease: A systematic review. [PDF]
Aishwarya A +3 more
europepmc +1 more source
What has changed in thyroid eye disease in the last five years (2020-2025). [PDF]
Salvi M.
europepmc +1 more source
Thyroid eye disease in paediatric Graves' disease: a case series from the Gulf region with comparison to adults. [PDF]
Aljufairi FMAA +14 more
europepmc +1 more source
Baseline selenium is associated with response to intravenous Methylprednisolone with selenium supplementation for thyroid eye disease in a selenium-sufficient area. [PDF]
Sung SM, Lee DC.
europepmc +1 more source
Thyroid Eye Disease, Glycemic Control, and the Role of a One-Stop Clinic Approach: A Retrospective Audit Study. [PDF]
Carter K +6 more
europepmc +1 more source
Approach to the patient: therapeutic mitigation of lacrimal manifestations in thyroid eye disease. [PDF]
Reinhardt C +5 more
europepmc +1 more source
The Management of Thyroid Eye Disease: From Current Practice to Future Perspectives. [PDF]
Dhaliwal NK, Razzaq L.
europepmc +1 more source

